Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Did Inovio Pharmaceuticals (NASDAQ:INO) Lose USD 49.2 Million as VOCERYQ Won FDA Approval?

Key HighlightsNet loss for the third quarter of 2026 was USD 49.2 million, or USD 0.50 per share, against USD 45.5 million, or USD 0.87, a year earlier, with USD 26.9 million from a non-cash change inWarrantliabilities.Loss from operations narrowed to USD 19.5 million …

Vinay Lochav | 12 November 2026

Why Did Acadia Pharmaceuticals (NASDAQ:ACAD) Jump 10.79% After the Nuplazid Patent Hearing?

Acadia reported third-quarter 2026Revenueof USD 342 million, up 22% from a year earlier, driven by both Nuplazid and Daybue, its treatment for Rett syndrome. The company raised its Daybue sales guidance to USD 505 million to USD 520 million and set total revenue guidance …

Vinay Lochav | 12 November 2026

Why Is Innoviz Technologies (NASDAQ:INVZ) Cutting About 20% of Staff After USD 12.1 Million Sales?

Management is implementing an operational realignment in the fourth quarter that it expects to save USD 17.5 million annualized, about USD 12 million of it from the workforce reduction and the rest from operating and capital spending. The company ended the quarter with about …

Vinay Lochav | 12 November 2026

How Did Equipment Sales Up 271% Lift Intelligent Protection Management (NASDAQ:IPM) Revenue 75.5%?

Cost of revenue jumped to USD 7.77 million from USD 3.08 million, so mix mattered more than volume. Sales andMarketingand administrative costs together fell to USD 3.26 million, and litigation expenses tied to the Cisco ManyCam matter were USD 317,818 against USD 507,181. Management …

Vinay Lochav | 12 November 2026

Why Did Liquidia (NASDAQ:LQDA) Rise 7.37% Despite a USD 389.7 Million Litigation Charge?

Under the agreement, Liquidia pays United Therapeutics USD 175 million within 30 business days, followed by two instalments of USD 72.7 million due by January 31 and April 30, 2027, while USD 60.3 million went to other parties in October 2026. Cash of USD …

Vinay Lochav | 12 November 2026

Why Did Opus Genetics (NASDAQ:IRD) Lose USD 46.5 Million on a USD 19.2 Million Operating Loss?

Key HighlightsNet loss for the third quarter of 2026 was USD 46.5 million, or USD 0.46 per share, against USD 17.5 million, or USD 0.25, a year earlier, as non-cashFair Valuechanges cost USD 28.6 million.Loss from operations was USD 19.2 million against USD 8.3 …

Vinay Lochav | 12 November 2026

What Does Blackstone's Up to USD 1.5 Billion Obesity Funding Deal Mean for Pfizer (NYSE:PFE)?

Key HighlightsPfizer (NYSE:PFE) announced on November 11, 2026 a strategic funding agreement under which funds managed by Blackstone Life Sciences will pay up to USD 1.5 billion of development costs through 2028.The money supports berobenatide, a once-monthly GLP-1 receptor agonist in Phase 3 development …

Vinay Lochav | 12 November 2026

Why Did ITG (NYSE:ITG) Burn Cash Despite 49% Revenue Growth and USD 64.5 Million Adjusted EBITDA?

Adjusted EBITDA of USD 64.5 million was slightly ahead of management's forecast. The margin of 14% rose as start-up costs on new business eased and acquisitions changed the mix, though higher fuel costs, a little under 1% of sales year over year, remain a …

Vinay Lochav | 12 November 2026

Can Venture Global (NYSE:VG) Deliver Up to USD 10.3 Billion in EBITDA After Plaquemines Goes Commercial?

Key HighlightsVenture Global (NYSE:VG) reported third-quarter 2026Revenueof USD 4.756 billion on November 10, 2026, up 43% from a year earlier.Net income attributable to common stockholders rose 493% to USD 2.546 billion, and consolidated adjusted EBITDA increased 69% to USD 2.583 billion.The company raised its …

Vinay Lochav | 12 November 2026

Why Did Janus International Group (NYSE:JBI) Lose USD 13.3 Million With USD 18.3 Million Charges?

Key HighlightsNet loss for the third quarter of 2026, ended October 3, was USD 13.3 million, againstNet Incomeof USD 15.2 million a year earlier, after USD 18.3 million ofGoodwilland tradenameImpairmentcharges.Revenue was USD 213.1 million, down 2.8% from USD 219.3 million, while adjusted EBITDA fell …

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…